| Year |
Citation |
Score |
| 2023 |
Swann R, Slikboer S, Genady A, Silva LR, Janzen N, Faraday A, Valliant JF, Sadeghi S. Tetrazine-Derived Near-Infrared Dye for Targeted Photoacoustic Imaging of Bone. Journal of Medicinal Chemistry. 66: 6025-6036. PMID 37129217 DOI: 10.1021/acs.jmedchem.2c01685 |
0.763 |
|
| 2020 |
Slikboer SR, Pitchumony TS, Banevicius L, Mercanti N, Edem PE, Valliant JF. Imidazole fused phenanthroline (PIP) ligands for the preparation of multimodal Re(I) and Tc(I) probes. Dalton Transactions (Cambridge, England : 2003). PMID 33034336 DOI: 10.1039/d0dt02829k |
0.774 |
|
| 2020 |
Slikboer S, Naperstkow Z, Janzen N, Faraday A, Soenjaya Y, Le Floc'h J, Al-Karmi S, Swann R, Wyszatko K, Demore CEM, Foster S, Valliant JF. A Tetrazine-Derived Near-Infrared Dye as a Facile Reagent for Developing Targeted Photoacoustic Imaging Agents. Molecular Pharmaceutics. PMID 32697098 DOI: 10.1021/Acs.Molpharmaceut.0C00441 |
0.791 |
|
| 2019 |
Mercanti N, Bilton H, Janzen N, Valliant J. Moving towards clinical translation of bioorthogonal chemistry: preparation and testing of a 99mTc instant kit for imaging and treating bone injury using inverse-electron demand Diels-Alder (IEDDA) chemistry Nuclear Medicine and Biology. DOI: 10.1016/S0969-8051(19)30272-0 |
0.331 |
|
| 2019 |
Slikboer S, Naperstkow Z, Janzen N, Valliant J. A new approach for labelling near-infrared dyes with 99mTc for combined SPECT and photoacoustic imaging of calcium accretion Nuclear Medicine and Biology. DOI: 10.1016/S0969-8051(19)30196-9 |
0.325 |
|
| 2017 |
Le Floc'h J, Zlitni A, Bilton HA, Yin M, Farhadi A, Janzen NR, Shapiro MG, Valliant JF, Foster FS. In vivo Biodistribution of Radiolabeled Acoustic Protein Nanostructures. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 28956265 DOI: 10.1007/S11307-017-1122-6 |
0.737 |
|
| 2017 |
Yazdani A, Janzen N, Czorny S, Ungard RG, Miladinovic T, Singh G, Valliant JF. Preparation of tetrazine-containing [2 + 1] complexes of (99m)Tc and in vivo targeting using bioorthogonal inverse electron demand Diels-Alder chemistry. Dalton Transactions (Cambridge, England : 2003). PMID 28640297 DOI: 10.1039/c7dt01497j |
0.316 |
|
| 2017 |
Zlitni A, Yin M, Janzen N, Chatterjee S, Lisok A, Gabrielson KL, Nimmagadda S, Pomper MG, Foster FS, Valliant JF. Development of prostate specific membrane antigen targeted ultrasound microbubbles using bioorthogonal chemistry. Plos One. 12: e0176958. PMID 28472168 DOI: 10.1371/Journal.Pone.0176958 |
0.739 |
|
| 2017 |
Bilton HA, Ahmad Z, Janzen N, Czorny S, Valliant JF. Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry. Journal of Visualized Experiments : Jove. PMID 28190049 DOI: 10.3791/55188 |
0.784 |
|
| 2016 |
Vito A, Alarabi H, Czorny S, Beiraghi O, Kent J, Janzen N, Genady AR, Alkarmi SA, Rathmann S, Naperstkow Z, Blacker M, Llano L, Berti PJ, Valliant JF. A 99mTc-Labelled Tetrazine for Bioorthogonal Chemistry. Synthesis and Biodistribution Studies with Small Molecule trans-Cyclooctene Derivatives. Plos One. 11: e0167425. PMID 27936007 DOI: 10.1371/journal.pone.0167425 |
0.303 |
|
| 2016 |
Yazdani A, Bilton H, Vito A, Genady AR, Rathmann SM, Ahmad Z, Janzen N, Czorny S, Zeglis BM, Francesconi LC, Valliant JF. A Bone-Seeking Trans-Cyclooctene for Pretargeting and Bioorthogonal Chemistry: A Proof of Concept Study Using 99mTc- and 177Lu-Labeled Tetrazines. Journal of Medicinal Chemistry. PMID 27676258 DOI: 10.1021/Acs.Jmedchem.6B00938 |
0.759 |
|
| 2016 |
Rathmann SM, Janzen N, Valliant JF. Synthesis, radiolabelling, and biodistribution studies of triazole derivatives for targeting melanoma Canadian Journal of Chemistry. 94: 773-780. DOI: 10.1139/cjc-2016-0239 |
0.324 |
|
| 2015 |
Albu SA, Al-Karmi S, Vito A, Dzandzi JP, Zlitni A, Beckford-Vera D, Blacker M, Janzen N, Patel R, Capretta A, Valliant JF. 125I-Tetrazines and Inverse-Electron-Demand Diels-Alder Chemistry: A Convenient Radioiodination Strategy for Biomolecule Labeling, Screening and Biodistribution Studies. Bioconjugate Chemistry. PMID 26699913 DOI: 10.1021/acs.bioconjchem.5b00609 |
0.746 |
|
| 2015 |
Yazdani A, Janzen N, Banevicius L, Czorny S, Valliant JF. Imidazole-based [2 + 1] Re(I)/99mTc(I) complexes as isostructural nuclear and optical probes. Inorganic Chemistry. 54: 1728-36. PMID 25634699 DOI: 10.1021/ic502663p |
0.307 |
|
| 2015 |
Schaffer P, Bénard F, Bernstein A, Buckley K, Celler A, Cockburn N, Corsaut J, Dodd M, Economou C, Eriksson T, Frontera M, Hanemaayer V, Hook B, Klug J, Kovacs M, ... ... Valliant J, et al. Direct Production of 99mTc via 100Mo(p,2n) on Small Medical Cyclotrons Physics Procedia. 66: 383-395. DOI: 10.1016/J.Phpro.2015.05.048 |
0.458 |
|
| 2015 |
Genady AR, Tan J, El-Zaria ME, Zlitni A, Janzen N, Valliant JF. Reprint of: Synthesis, characterization and radiolabeling of carborane-functionalized tetrazines for use in inverse electron demand Diels-Alder ligation reactions Journal of Organometallic Chemistry. 798: 278-288. DOI: 10.1016/j.jorganchem.2015.10.030 |
0.72 |
|
| 2014 |
Zlitni A, Janzen N, Foster FS, Valliant JF. Catching bubbles: targeting ultrasound microbubbles using bioorthogonal inverse-electron-demand Diels-Alder reactions. Angewandte Chemie (International Ed. in English). 53: 6459-63. PMID 24829138 DOI: 10.1002/anie.201402473 |
0.732 |
|
| 2014 |
Bénard F, Buckley KR, Ruth TJ, Zeisler SK, Klug J, Hanemaayer V, Vuckovic M, Hou X, Celler A, Appiah JP, Valliant J, Kovacs MS, Schaffer P. Implementation of Multi-Curie Production of (99m)Tc by Conventional Medical Cyclotrons. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1017-22. PMID 24722529 DOI: 10.2967/Jnumed.113.133413 |
0.515 |
|
| 2014 |
Zlitni A, Genady AR, Janzen N, Valliant JF. The preparation and preclinical evaluation of 99mTc-labeled microbubbles for bimodal ultrasound and SPECT imaging Nuclear Medicine and Biology. 41: 628. DOI: 10.1016/j.nucmedbio.2014.05.099 |
0.749 |
|
| 2014 |
Buckley K, Benard F, Kovacs M, Hanemaayer V, Hook B, McDiarmid S, Zeisler S, Dodd M, Corsaut J, Vuckovic M, Cockburn N, Economou C, Harper R, Valliant J, Ruth T, et al. Large-scale cyclotron production of 99mTc Nuclear Medicine and Biology. 41: 647. DOI: 10.1016/J.Nucmedbio.2014.05.070 |
0.47 |
|
| 2012 |
Darwish A, Blacker M, Janzen N, Rathmann SM, Czorny S, Hillier SM, Joyal JL, Babich JW, Valliant JF. Triazole Appending Agent (TAAG): A New Synthon for Preparing Iodine-Based Molecular Imaging and Radiotherapy Agents. Acs Medicinal Chemistry Letters. 3: 313-6. PMID 24900470 DOI: 10.1021/ml300003v |
0.304 |
|
| 2012 |
El-Zaria ME, Janzen N, Blacker M, Valliant JF. Synthesis, characterisation, and biodistribution of radioiodinated C-hydroxy-carboranes. Chemistry (Weinheim An Der Bergstrasse, Germany). 18: 11071-8. PMID 22807279 DOI: 10.1002/chem.201200833 |
0.31 |
|
| 2012 |
Klug J, Buckley KR, Zeisler SK, Dodd M, Tsao P, Hoehr C, Economou C, Corsaut J, Appiah JP, Kovacs MS, Valliant JF, Benard F, Ruth TJ, Schaffer P. A new transfer system for solid targets Aip Conference Proceedings. 1509: 146-151. DOI: 10.1063/1.4773957 |
0.496 |
|
| 2012 |
Louie AS, Harrington LE, Valliant JF. The preparation and characterization of functionalized carboranes and Re/Tc-metallocarboranes as platforms for developing molecular imaging probes: Structural and cage isomerism studies Inorganica Chimica Acta. 389: 159-167. DOI: 10.1016/J.Ica.2012.03.017 |
0.349 |
|
| 2012 |
Simms RW, Causey PW, Weaver DM, Sundararajan C, Stephenson KA, Valliant JF. Preparation of technetium-99m bifunctional chelate complexes using a microfluidic reactor: A comparative study with conventional and microwave labeling methods Journal of Labelled Compounds and Radiopharmaceuticals. 55: 18-22. DOI: 10.1002/Jlcr.1946 |
0.771 |
|
| 2011 |
Lazarova N, Causey PW, Lemon JA, Czorny SK, Forbes JR, Zlitni A, Genady A, Foster FS, Valliant JF. The synthesis, magnetic purification and evaluation of 99mTc-labeled microbubbles. Nuclear Medicine and Biology. 38: 1111-8. PMID 21741260 DOI: 10.1016/J.Nucmedbio.2011.04.008 |
0.776 |
|
| 2011 |
Hicks JW, Harrington LE, Valliant JF. Fluorous ligand capture (FLC): a chemoselective solution-phase strategy for isolating 99mTc-labelled compounds in high effective specific activity. Chemical Communications (Cambridge, England). 47: 7518-20. PMID 21625674 DOI: 10.1039/C1Cc11079A |
0.323 |
|
| 2009 |
Maresca KP, Hillier SM, Femia FJ, Zimmerman CN, Levadala MK, Banerjee SR, Hicks J, Sundararajan C, Valliant J, Zubieta J, Eckelman WC, Joyal JL, Babich JW. Comprehensive radiolabeling, stability, and tissue distribution studies of technetium-99m single amino acid chelates (SAAC). Bioconjugate Chemistry. 20: 1625-33. PMID 19572702 DOI: 10.1021/Bc900192B |
0.373 |
|
| 2009 |
Bartholomä M, Valliant J, Maresca KP, Babich J, Zubieta J. Single amino acid chelates (SAAC): a strategy for the design of technetium and rhenium radiopharmaceuticals. Chemical Communications (Cambridge, England). 493-512. PMID 19283279 DOI: 10.1039/B814903H |
0.352 |
|
| 2008 |
Armstrong AF, Oakley N, Parker S, Causey PW, Lemon J, Capretta A, Zimmerman C, Joyal J, Appoh F, Zubieta J, Babich JW, Singh G, Valliant JF. A robust strategy for the preparation of libraries of metallopeptides. A new paradigm for the discovery of targeted molecular imaging and therapy agents. Chemical Communications (Cambridge, England). 5532-4. PMID 18997942 DOI: 10.1039/B810706H |
0.786 |
|
| 2008 |
McIntee JW, Sundararajan C, Donovan AC, Kovacs MS, Capretta A, Valliant JF. A convenient method for the preparation of fluorous tin derivatives for the fluorous labeling strategy. The Journal of Organic Chemistry. 73: 8236-43. PMID 18826327 DOI: 10.1021/Jo8013287 |
0.336 |
|
| 2008 |
Causey PW, Besanger TR, Schaffer P, Valliant JF. Expedient multi-step synthesis of organometallic complexes of Tc and Re in high effective specific activity. A new platform for the production of molecular imaging and therapy agents. Inorganic Chemistry. 47: 8213-21. PMID 18710215 DOI: 10.1021/Ic800775W |
0.808 |
|
| 2008 |
Causey PW, Besanger TR, Valliant JF. Synthesis and screening of mono- and di-aryl technetium and rhenium metallocarboranes. A new class of probes for the estrogen receptor. Journal of Medicinal Chemistry. 51: 2833-44. PMID 18412324 DOI: 10.1021/Jm701561E |
0.751 |
|
| 2008 |
Schaffer P, Gleave JA, Lemon JA, Reid LC, Pacey LK, Farncombe TH, Boreham DR, Zubieta J, Babich JW, Doering LC, Valliant JF. Isostructural fluorescent and radioactive probes for monitoring neural stem and progenitor cell transplants. Nuclear Medicine and Biology. 35: 159-69. PMID 18312825 DOI: 10.1016/J.Nucmedbio.2007.11.001 |
0.505 |
|
| 2008 |
Green AEC, Harrington LE, Valliant JF. Carborane-carbohydrate derivatives - Versatile platforms for developing targeted radiopharmaceuticals Canadian Journal of Chemistry. 86: 1063-1069. DOI: 10.1139/V08-157 |
0.355 |
|
| 2006 |
Green AE, Causey PW, Louie AS, Armstrong AF, Harrington LE, Valliant JF. Microwave-assisted synthesis of 3,1,2- and 2,1,8-Re(I) and 99mTc(I)-metallocarborane complexes. Inorganic Chemistry. 45: 5727-9. PMID 16841972 DOI: 10.1021/Ic0605928 |
0.776 |
|
| 2006 |
Donovan A, Forbes J, Dorff P, Schaffer P, Babich J, Valliant JF. A new strategy for preparing molecular imaging and therapy agents using fluorine-rich (fluorous) soluble supports. Journal of the American Chemical Society. 128: 3536-7. PMID 16536524 DOI: 10.1021/ja0600375 |
0.599 |
|
| 2006 |
Guenther KJ, Yoganathan S, Garofalo R, Kawabata T, Strack T, Labiris R, Dolovich M, Chirakal R, Valliant JF. Synthesis and in vitro evaluation of 18F- and 19F-labeled insulin: a new radiotracer for PET-based molecular imaging studies. Journal of Medicinal Chemistry. 49: 1466-74. PMID 16480283 DOI: 10.1021/Jm0509344 |
0.591 |
|
| 2006 |
Riddoch RW, Schaffer P, Valliant JF. A solid-phase labeling strategy for the preparation of technetium and rhenium bifunctional chelate complexes and associated peptide conjugates. Bioconjugate Chemistry. 17: 226-35. PMID 16417273 DOI: 10.1021/bc050216w |
0.555 |
|
| 2005 |
Sogbein OO, Green AE, Schaffer P, Chankalal R, Lee E, Healy BD, Morel P, Valliant JF. Synthesis of ortho- and meta-Re(I)-metallocarboranes in water. Inorganic Chemistry. 44: 9574-84. PMID 16323947 DOI: 10.1021/ic0511221 |
0.497 |
|
| 2005 |
Banerjee SR, Schaffer P, Babich JW, Valliant JF, Zubieta J. Design and synthesis of site directed maleimide bifunctional chelators for technetium and rhenium. Dalton Transactions (Cambridge, England : 2003). 3886-97. PMID 16311643 DOI: 10.1039/B507096A |
0.54 |
|
| 2005 |
Lazarova N, Babich J, Valliant J, Schaffer P, James S, Zubieta J. Thiol- and thioether-based bifunctional chelates for the {M(CO)3}+ core (M = Tc, Re). Inorganic Chemistry. 44: 6763-70. PMID 16156635 DOI: 10.1021/Ic050735A |
0.543 |
|
| 2005 |
Banerjee SR, Maresca KP, Francesconi L, Valliant J, Babich JW, Zubieta J. New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate design. Nuclear Medicine and Biology. 32: 1-20. PMID 15691657 DOI: 10.1016/J.Nucmedbio.2004.09.001 |
0.365 |
|
| 2004 |
Smith DS, Bell RA, Valliant J, Kramer JR. Determination of strong ligand sites in sewage effluent-impacted waters by competitive ligand titration with silver. Environmental Science & Technology. 38: 2120-5. PMID 15112815 DOI: 10.1021/Es035045P |
0.499 |
|
| 2003 |
Schaffer P, Britten JF, Davison A, Jones AG, Valliant JF. Synthesis of homoleptic Re(I) complexes of isocyano-carboranes and the X-ray structure of hexakis(p-carboran-1-yl-isonitrile)Re(I) Journal of Organometallic Chemistry. 680: 323-328. DOI: 10.1016/S0022-328X(03)00497-2 |
0.711 |
|
| 2003 |
Morel P, Schaffer P, Valliant JF. The synthesis and X-ray crystallographic structure determination of 3-isocyano-1,2-dicarba-closo-dodecaborane-Re(I) complexes Journal of Organometallic Chemistry. 668: 25-30. DOI: 10.1016/S0022-328X(02)02094-6 |
0.479 |
|
| 2002 |
Morel P, Schaffer P, Britten JF, Valliant JF. Solvent-metal interactions in bis[1,2-dicarba-closo-dodecaboran(12)-1-yl]mercury(II) dichloromethane solvate and bis[1,12-dicarba-closo-dodecaboran(12)-1-yl]mercury(II) tetrahydrofuran solvate. Acta Crystallographica. Section C, Crystal Structure Communications. 58: m601-4. PMID 12466611 DOI: 10.1107/S0108270102020036 |
0.478 |
|
| 2002 |
Schaffer P, Morel P, Britten JF, Valliant JF. Unexpected formation of an azetidine-carborane derivative by dehydration of N-(1,12-dicarba-closo-dodecaboran-1-yl)formamide. The first X-ray structure of a 2,3-bis(imino)azetidine. Inorganic Chemistry. 41: 6493-9. PMID 12444795 DOI: 10.1021/Ic025828W |
0.467 |
|
| 2002 |
Valliant JF, Sogbein OO, Morel P, Schaffer P, Guenther KJ, Bain AD. Synthesis, NMR, and X-ray crystallographic analysis of C-hydrazino-C-carboxycarboranes: versatile ligands for the preparation of BNCT and BNCS agents and (99m)Tc radiopharmaceuticals. Inorganic Chemistry. 41: 2731-7. PMID 12005497 DOI: 10.1021/ic0255048 |
0.503 |
|
| 2002 |
Valliant JF, Morel P, Schaffer P, Kaldis JH. Carboranes as ligands for the preparation of organometallic Tc and Re Radiopharmaceuticals. Synthesis of [M(CO)(3)(eta-2,3-C(2)B(9)H(11))](-) and rac-[M(CO)(3)(eta-2-R-2,3-C(2)B(9)H(10))](-) (M = Re, (99)Tc; R = CH(2)CH(2)CO(2)H) from [M(CO)(3)Br(3)](2-). Inorganic Chemistry. 41: 628-30. PMID 11849058 DOI: 10.1021/ic0156285 |
0.506 |
|
| 2002 |
Valliant JF, Schaffer P, Stephenson KA, Britten JF. Synthesis of boroxifen, a nido-carborane analogue of tamoxifen. The Journal of Organic Chemistry. 67: 383-7. PMID 11798307 DOI: 10.1021/jo0158229 |
0.524 |
|
| 2002 |
Morel P, Schaffer P, Britten JF, Valliant JF. Solvent-metal interactions in bis[1,2-dicarba-closo-dodeca-boran(12)-1-yl]mercury(II) dichloro-methane solvate and bis[1,12-dicarba-closo-dodecaboran(12)-1-yl]-mercury(II) tetrahydrofuran solvate Acta Crystallographica Section C: Crystal Structure Communications. 58: m601-m604. DOI: 10.1107/S0108270102020036 |
0.438 |
|
| 2002 |
Valliant JF, Guenther KJ, King AS, Morel P, Schaffer P, Sogbein OO, Stephenson KA. The medicinal chemistry of carboranes Coordination Chemistry Reviews. 232: 173-230. DOI: 10.1016/S0010-8545(02)00087-5 |
0.507 |
|
| 2001 |
Valliant JF, Schaffer P. A new approach for the synthesis of isonitrile carborane derivatives. Ligands for metal based boron neutron capture therapy (BNCT) and boron neutron capture synovectomy (BNCS) agents. Journal of Inorganic Biochemistry. 85: 43-51. PMID 11377694 DOI: 10.1016/S0162-0134(00)00222-1 |
0.536 |
|
| 2000 |
Valliant JF, Schaffer P, Britten JF, Davison A, Jones AG, Yanch JC. The synthesis of corticosteroid-carborane esters for the treatment of rheumatoid arthritis via boron neutron capture synovectomy Tetrahedron Letters. 41: 1355-1358. DOI: 10.1016/S0040-4039(99)02292-3 |
0.669 |
|
| 1999 |
Bell RA, Dickson KC, Valliant JF. The total synthesis of a technetium chelate - Tamoxifen complex Canadian Journal of Chemistry. 77: 146-154. |
0.493 |
|
| 1999 |
Bain AD, Bell RA, Fletcher DA, Hazendonk P, Maharajh RA, Rigby S, Valliant JF. NMR studies of chemical exchange amongst five conformers of a ten-membered ring compound containing two amide bonds and a disulfide Journal of the Chemical Society. Perkin Transactions 2. 1447-1453. |
0.432 |
|
| 1998 |
Bell RA, McCarry BE, Valliant JF. The Synthesis, NMR Spectroscopy, and X-ray Structure of a New Rhenium N(2)S(2) Chelate Complex. Inorganic Chemistry. 37: 3517-3520. PMID 11670436 DOI: 10.1021/Ic970654H |
0.487 |
|
| 1998 |
Bell RA, Lock CJL, Scholten C, Valliant JF. The synthesis, NMR and X-ray analysis of tris(1-ethyl-2-isopropylimidazol-5-yl)phosphine gold(I)-2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranoside, a bifunctional auranofin analogue Inorganica Chimica Acta. 274: 137-142. DOI: 10.1016/S0020-1693(97)06039-8 |
0.465 |
|
| 1997 |
Wong E, Fauconnier T, Bennett S, Valliant J, Nguyen T, Lau F, Lu LF, Pollak A, Bell RA, Thornback JR. Rhenium(V) and Technetium(V) Oxo Complexes of an N(2)N'S Peptidic Chelator: Evidence of Interconversion between the Syn and Anti Conformations. Inorganic Chemistry. 36: 5799-5808. PMID 11670202 DOI: 10.1021/Ic9706562 |
0.541 |
|
| 1997 |
Bell RA, Britten JF, Guest A, Lock CJL, Valliant JF. Tetrakis(cyclopentamethylenedithiocarbamate-S,S′)technetium(v) bromide, an unusual eight-coordinate complex of technetium(v) Chemical Communications. 585-586. |
0.43 |
|
| 1996 |
Bell RA, Hughes DW, Lock CJL, Valliant JF. The synthesis and high-resolution NMR spectroscopy of ethyl N-(2-triphenylmethylthio)ethanoyl-O-{4'-[4''-(1''-bis(2'''-chloroethy l)amino)phenyl]butanoyl}-L-seryl-S-benzyl-L-cysteine: A chelate-chlorambucil complex for use as a ligand for 99mTc radio-imaging Canadian Journal of Chemistry. 74: 1503-1511. |
0.484 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2019 |
Wyszatko K, Valliant J, Bilton H, Janzen N. Targeted radiopharmaceuticals for nuclear imaging and radiotherapy of CD133-positive tumors Nuclear Medicine and Biology. DOI: 10.1016/S0969-8051(19)30323-3 |
0.298 |
|
| 2017 |
Yazdani A, Janzen N, Czorny S, Valliant JF. Technetium(I) Complexes of Bathophenanthrolinedisulfonic Acid. Inorganic Chemistry. PMID 28199089 DOI: 10.1021/acs.inorgchem.6b03058 |
0.296 |
|
| 2019 |
Juergens RA, Zukotynski KA, Juneau D, Krnezich L, Simms R, Forbes J, Burak ES, Valliant J, Stafford L, Armor T, Molnar I, Saad F. A phase I study of [225Ac]-FPI-1434 radioimmunotherapy in patients with IGF-1R expressing solid tumors. Journal of Clinical Oncology. 37: TPS3152-TPS3152. DOI: 10.1200/Jco.2019.37.15_Suppl.Tps3152 |
0.295 |
|
| 2009 |
Parrott MC, Benhabbour SR, Saab C, Lemon JA, Parker S, Valliant JF, Adronov A. Synthesis, radiolabeling, and bio-imaging of high-generation polyester dendrimers. Journal of the American Chemical Society. 131: 2906-16. PMID 19239268 DOI: 10.1021/Ja8078175 |
0.292 |
|
| 2019 |
Edem PE, Sinnes JP, Pektor S, Bausbacher N, Rossin R, Yazdani A, Miederer M, Kjær A, Valliant JF, Robillard MS, Rösch F, Herth MM. Evaluation of the inverse electron demand Diels-Alder reaction in rats using a scandium-44-labelled tetrazine for pretargeted PET imaging. Ejnmmi Research. 9: 49. PMID 31140047 DOI: 10.1186/s13550-019-0520-y |
0.288 |
|
| 2020 |
Glicksman RM, Metser U, Valliant J, Chung PW, Fleshner NE, Bristow RG, Green D, Finelli A, Hamilton R, Stanescu T, Hussey D, Catton C, Gospodarowicz M, Warde P, Bayley A, et al. [F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial. Bmj Open. 10: e035959. PMID 32327479 DOI: 10.1136/Bmjopen-2019-035959 |
0.276 |
|
| 2011 |
Braband H, Tooyama Y, Fox T, Simms R, Forbes J, Valliant JF, Alberto R. fac-[TcO3(tacn)]+: a versatile precursor for the labelling of pharmacophores, amino acids and carbohydrates through a new ligand-centred labelling strategy. Chemistry (Weinheim An Der Bergstrasse, Germany). 17: 12967-74. PMID 21971703 DOI: 10.1002/Chem.201101275 |
0.275 |
|
| 2013 |
Pitchumony TS, Banevicius L, Janzen N, Zubieta J, Valliant JF. Isostructural nuclear and luminescent probes derived from stabilized [2 + 1] rhenium(I)/technetium(I) organometallic complexes. Inorganic Chemistry. 52: 13521-8. PMID 24228697 DOI: 10.1021/ic401972g |
0.273 |
|
| 2019 |
Stéen EJL, Jørgensen JT, Petersen IN, Nørregaard K, Lehel S, Shalgunov V, Birke A, Edem PE, L'Estrade ET, Hansen HD, Villadsen J, Erlandsson M, Ohlsson T, Yazdani A, Valliant JF, et al. Improved radiosynthesis and preliminary in vivo evaluation of the C-labeled tetrazine [C]AE-1 for pretargeted PET imaging. Bioorganic & Medicinal Chemistry Letters. PMID 30795854 DOI: 10.1016/j.bmcl.2019.02.014 |
0.273 |
|
| 2005 |
Banerjee SR, Maresca KP, Stephenson KA, Valliant JF, Babich JW, Graham WA, Barzana M, Dong Q, Fischman AJ, Zubieta J. N,N-bis(2-mercaptoethyl)methylamine: a new coligand for Tc-99m labeling of hydrazinonicotinamide peptides. Bioconjugate Chemistry. 16: 885-902. PMID 16029030 DOI: 10.1021/Bc050040Y |
0.272 |
|
| 2019 |
Bilton H, Janzen N, Valliant J. Drug formulation and its impact on the distribution of [99mTc] Tc-tetrazines for pretargeting applications via inverse-electron demand Diels-Alder chemistry Nuclear Medicine and Biology. DOI: 10.1016/S0969-8051(19)30260-4 |
0.267 |
|
| 2015 |
McNelles SA, Knight SD, Janzen N, Valliant JF, Adronov A. Synthesis, Radiolabeling, and In Vivo Imaging of PEGylated High-Generation Polyester Dendrimers. Biomacromolecules. 16: 3033-41. PMID 26295201 DOI: 10.1021/Acs.Biomac.5B00911 |
0.267 |
|
| 2006 |
James S, Maresca KP, Allis DG, Valliant JF, Eckelman W, Babich JW, Zubieta J. Extension of the single amino acid chelate concept (SAAC) to bifunctional biotin analogues for complexation of the M(CO)3(+1) Core (M = Tc and Re): syntheses, characterization, biotinidase stability, and avidin binding. Bioconjugate Chemistry. 17: 579-89. PMID 16704194 DOI: 10.1021/Bc050297W |
0.266 |
|
| 2005 |
Sogbein OO, Green AE, Valliant JF. Aqueous fluoride and the preparation of [99mTc(CO)3(OH2)3]+ and 99mTc-carborane complexes. Inorganic Chemistry. 44: 9585-91. PMID 16323948 DOI: 10.1021/ic051123t |
0.264 |
|
| 2016 |
Sadowski LP, Edem PE, Valliant JF, Adronov A. Synthesis of Polyester Dendritic Scaffolds for Biomedical Applications. Macromolecular Bioscience. PMID 27376967 DOI: 10.1002/Mabi.201600154 |
0.262 |
|
| 2019 |
Schaffer P, Benard F, Vuckovic M, Zeisler S, Anazodo U, Romsa J, Cross M, Foster S, Gleeson F, Hayashi K, Hook B, Kumlin J, Buckley K, Schlosser J, Wilson K, ... ... Valliant J, et al. Cyclotron-based production of Tc-99m and other metals Nuclear Medicine and Biology. DOI: 10.1016/S0969-8051(19)30209-4 |
0.262 |
|
| 2010 |
Armstrong AF, Valliant JF. Differences between the macroscopic and tracer level chemistry of rhenium and technetium: contrasting cage isomerisation behaviour of Re(I) and Tc(I) carborane complexes. Dalton Transactions (Cambridge, England : 2003). 39: 8128-31. PMID 20694253 DOI: 10.1039/c0dt00490a |
0.257 |
|
| 2006 |
James S, Maresca KP, Babich JW, Valliant JF, Doering L, Zubieta J. Isostructural Re and 99mTc complexes of biotin derivatives for fluorescence and radioimaging studies. Bioconjugate Chemistry. 17: 590-6. PMID 16704195 DOI: 10.1021/Bc050298O |
0.256 |
|
| 2004 |
Stephenson KA, Banerjee SR, Besanger T, Sogbein OO, Levadala MK, McFarlane N, Lemon JA, Boreham DR, Maresca KP, Brennan JD, Babich JW, Zubieta J, Valliant JF. Bridging the gap between in vitro and in vivo imaging: isostructural Re and 99mTc complexes for correlating fluorescence and radioimaging studies. Journal of the American Chemical Society. 126: 8598-9. PMID 15250681 DOI: 10.1021/Ja047751B |
0.254 |
|
| 2019 |
Rathmann S, Janzen N, Valliant J. A Versatile Immune-Stimulatory Actinium-225 Complex for Combination Radiotherapy and Antibody Recruiting Therapy Journal of Medical Imaging and Radiation Sciences. 50: S32. DOI: 10.1016/J.Jmir.2019.03.097 |
0.25 |
|
| 2010 |
Bartholomä MD, Louie AS, Valliant JF, Zubieta J. Technetium and gallium derived radiopharmaceuticals: comparing and contrasting the chemistry of two important radiometals for the molecular imaging era. Chemical Reviews. 110: 2903-20. PMID 20415476 DOI: 10.1021/Cr1000755 |
0.25 |
|
| 2009 |
Donovan AC, Valliant JF. Fluorous isocyanates: convenient synthons for the preparation of radioiodinated compounds in high effective specific activity. The Journal of Organic Chemistry. 74: 8133-8. PMID 19799396 DOI: 10.1021/jo901475d |
0.248 |
|
| 2019 |
Grinshtein N, Simms R, Hu M, Storozhuk Y, Moran M, Burak E, Forbes J, Valliant J. IGF-1R Targeted Alpha Therapeutic FPI-1434 causes DNA Double-stranded Breaks and Induces Regression in Preclinical Models of Human Cancer Journal of Medical Imaging and Radiation Sciences. 50: S17-S18. DOI: 10.1016/J.Jmir.2019.03.056 |
0.244 |
|
| 2004 |
Sogbein OO, Merdy P, Morel P, Valliant JF. Preparation of Re(I)- and (99m)Tc(I)-metallocarboranes in water under weakly basic reaction conditions. Inorganic Chemistry. 43: 3032-4. PMID 15132607 DOI: 10.1021/ic049887g |
0.243 |
|
| 2019 |
Rathmann S, Genady A, Janzen N, Rullo A, Valliant J. A versatile immune-stimulatory radiometal complex for combination radiotherapy and immunotherapy Nuclear Medicine and Biology. DOI: 10.1016/S0969-8051(19)30223-9 |
0.243 |
|
| 2019 |
Ahmad Z, Janzen N, Valliant J. A platform for delivery of small molecules using trans-cyclooctene-functionalized pluronic F127 micelles Nuclear Medicine and Biology. DOI: 10.1016/S0969-8051(19)30365-8 |
0.242 |
|
| 2002 |
Lu C, Pelton R, Valliant J, Bothwell S, Stephenson K. Colloidal flocculation with poly(ethylene oxide)/polypeptide complexes Langmuir. 18: 4536-4538. DOI: 10.1021/La015697W |
0.238 |
|
| 2005 |
Stephenson KA, Banerjee SR, McFarlane N, Boreham DR, Maresca KP, Babich JW, Zubieta J, Valliant JF. A convenient solid-phase synthesis methodology for preparing peptide-derived molecular imaging agents - Synthesis, characterization, and in vitro screening of Tc(I) - chemotactic peptide conjugates Canadian Journal of Chemistry. 83: 2060-2066. DOI: 10.1139/V05-224 |
0.238 |
|
| 2008 |
Donovan AC, Valliant JF. A convenient solution-phase method for the preparation of meta-iodobenzylguanidine in high effective specific activity. Nuclear Medicine and Biology. 35: 741-6. PMID 18848658 DOI: 10.1016/j.nucmedbio.2008.07.006 |
0.235 |
|
| 2018 |
Zukotynski KA, Valliant J, Bénard F, Rowe SP, Kim CK, Pomper MG, Cho SY. Flare on Serial Prostate-Specific Membrane Antigen-Targeted 18F-DCFPyL PET/CT Examinations in Castration-Resistant Prostate Cancer: First Observations. Clinical Nuclear Medicine. PMID 29356735 DOI: 10.1097/Rlu.0000000000001966 |
0.234 |
|
| 2020 |
Edem PE, Jørgensen JT, Nørregaard K, Rossin R, Yazdani A, Valliant JF, Robillard M, Herth MM, Kjaer A. Evaluation of a Ga-Labeled DOTA-Tetrazine as a PET Alternative to In-SPECT Pretargeted Imaging. Molecules (Basel, Switzerland). 25. PMID 31979070 DOI: 10.3390/molecules25030463 |
0.23 |
|
| 2009 |
Armstrong AF, Lemon JA, Czorny SK, Singh G, Valliant JF. Evaluation of single amino acid chelate derivatives and regioselective radiolabelling of a cyclic peptide for the urokinase plasminogen activator receptor. Nuclear Medicine and Biology. 36: 907-17. PMID 19875047 DOI: 10.1016/j.nucmedbio.2009.07.001 |
0.229 |
|
| 2012 |
Simms RW, Kim DH, Weaver DM, Sundararajan C, Blacker M, Stephenson KA, Valliant JF. Emulsion reactors: a new technique for the preparation of molecular imaging probes. Chemistry (Weinheim An Der Bergstrasse, Germany). 18: 6746-9. PMID 22532271 DOI: 10.1002/chem.201200049 |
0.227 |
|
| 2013 |
Toppino A, Genady AR, El-Zaria ME, Reeve J, Mostofian F, Kent J, Valliant JF. High yielding preparation of dicarba-closo-dodecaboranes using a silver(I) mediated dehydrogenative alkyne-insertion reaction. Inorganic Chemistry. 52: 8743-9. PMID 23829543 DOI: 10.1021/ic400928v |
0.224 |
|
| 2017 |
Amir N, Green D, Kent J, Xiang Y, Gorelikov I, Seo M, Blacker M, Janzen N, Czorny S, Valliant JF, Matsuura N. (18)F-Labeled perfluorocarbon droplets for positron emission tomography imaging. Nuclear Medicine and Biology. 54: 27-33. PMID 28863330 DOI: 10.1016/J.Nucmedbio.2017.07.001 |
0.222 |
|
| 2005 |
Stephenson KA, Banerjee SR, Sogbein OO, Levadala MK, McFarlane N, Boreham DR, Maresca KP, Babich JW, Zubieta J, Valliant JF. A new strategy for the preparation of peptide-targeted technetium and rhenium radiopharmaceuticals. The automated solid-phase synthesis, characterization, labeling, and screening of a peptide-ligand library targeted at the formyl peptide receptor. Bioconjugate Chemistry. 16: 1189-95. PMID 16173797 DOI: 10.1021/Bc0500591 |
0.22 |
|
| 2016 |
Tietz O, Dzandzi J, Bhardwaj A, Valliant JF, Wuest F. Design and synthesis of [(125)I]Pyricoxib: A novel (125)I-labeled cyclooxygenase-2 (COX-2) inhibitors. Bioorganic & Medicinal Chemistry Letters. PMID 26898334 DOI: 10.1016/j.bmcl.2016.02.029 |
0.22 |
|
| 2010 |
Edem PE, Valliant JF. Technetium-labelled cathepsin B inhibitors as molecular imaging agents Nuclear Medicine and Biology. 37: 681. DOI: 10.1016/j.nucmedbio.2010.04.164 |
0.219 |
|
| 2010 |
Simms RW, Stephenson KA, Valliant JF. A new platform for the preparation of 99mTc receptor targeted probes using droplet microreactors Nuclear Medicine and Biology. 37: 698. DOI: 10.1016/j.nucmedbio.2010.04.166 |
0.216 |
|
| 2019 |
Glicksman R, Metser U, Vines D, Chan R, Valliant J, Chung P, Gospodarowicz M, Bayley A, Catton C, Warde P, Helou J, Lalani N, Green D, Perlis N, Fleshner N, et al. Preliminary Results of a Two Stage Phase II Study of 18F-DCFPyL PET-MR for Enabling Oligometastases Ablative Therapy in Subclinical Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 105: E276. DOI: 10.1016/J.Ijrobp.2019.06.1901 |
0.216 |
|
| 2019 |
Wong RK, Myrehaug S, Brierley J, Laidley D, Juergens R, Yeung I, Breen S, Shessel A, Driscoll B, Farncombe T, Zukotynski K, Stodilka R, Caldwell C, Liu AZ, Valliant J, et al. 70 Quantifying Tumour Dose Using Individualized Dosimetry Methodology in 177LU Dotatate Therapy Radiotherapy and Oncology. 139: S32. DOI: 10.1016/S0167-8140(19)33360-2 |
0.216 |
|
| 2007 |
Armstrong AF, Valliant JF. The bioinorganic and medicinal chemistry of carboranes: from new drug discovery to molecular imaging and therapy. Dalton Transactions (Cambridge, England : 2003). 4240-51. PMID 17893811 DOI: 10.1039/b709843j |
0.214 |
|
| 2014 |
Coogan MP, Doyle RP, Valliant JF, Babich JW, Zubieta J. Single amino acid chelate complexes of the M(CO)3 (+) core for correlating fluorescence and radioimaging studies (M = (99m) Tc or Re). Journal of Labelled Compounds & Radiopharmaceuticals. 57: 255-61. PMID 24395431 DOI: 10.1002/Jlcr.3164 |
0.213 |
|
| 2013 |
Henry KE, Balasingham RG, Vortherms AR, Platts JA, Valliant JF, Coogan MP, Zubieta J, Doyle RP. Emission wavelength variation with changes in excitation in a Re(i)-bisthiazole ligand complex that breaks the Kasha-Vavilov rule Chemical Science. 4: 2490-2495. DOI: 10.1039/C3Sc22070B |
0.211 |
|
| 2020 |
Glicksman R, Metser U, Vines D, Chan R, Valliant J, Chung PWM, Gospodarowicz MK, Bayley A, Catton CN, Warde PR, Helou J, Raman S, Green D, Perlis N, Fleshner N, et al. Primary analysis of a phase II study of metastasis-directed ablative therapy to PSMA (18F-DCFPyL) PET-MR/CT defined oligorecurrent prostate cancer. Journal of Clinical Oncology. 38: 5553-5553. DOI: 10.1200/Jco.2020.38.15_Suppl.5553 |
0.211 |
|
| 2019 |
Wong R, Laidley D, Myrehaug S, Brierley J, Juergens R, Yeung I, Breen S, Driscoll B, Shessel A, Farncombe T, Zukotynski K, Stodilka R, Caldwell C, Liu Z, Valliant J, et al. Quantifying Renal And Tumor Doses with Individualized Dosimetry In 177Lu DOTATATE Therapy – What Difference Does It Make? International Journal of Radiation Oncology*Biology*Physics. 105: S205. DOI: 10.1016/J.Ijrobp.2019.06.273 |
0.204 |
|
| 2008 |
Stephenson KA, Reid LC, Zubieta J, Babich JW, Kung MP, Kung HF, Valliant JF. Synthesis and screening of a library of Re/Tc-based amyloid probes derived from beta-breaker peptides. Bioconjugate Chemistry. 19: 1087-94. PMID 18407681 DOI: 10.1021/Bc800001G |
0.203 |
|
| 2017 |
Ioppolo JA, Caldwell D, Beiraghi O, Llano L, Blacker M, Valliant JF, Berti PJ. (67)Ga-labeled deferoxamine derivatives for imaging bacterial infection: Preparation and screening of functionalized siderophore complexes. Nuclear Medicine and Biology. 52: 32-41. PMID 28602965 DOI: 10.1016/j.nucmedbio.2017.05.010 |
0.2 |
|
| 2011 |
Donovan AC, Valliant JF. Preparation and evaluation of reagents for tagging amino and thiol groups with fluorous stannanes. A convenient method for producing radioiodinated compounds in high effective specific activity Journal of Labelled Compounds and Radiopharmaceuticals. 54: 65-71. DOI: 10.1002/jlcr.1807 |
0.196 |
|
| 2016 |
Valliant JF. A Bridge Not Too Far: Linking Disciplines Through Molecular Imaging Probes. Journal of Nuclear Medicine Technology. 44: 173-83. PMID 27601414 DOI: 10.2967/jnumed.109.068312 |
0.189 |
|
| 2010 |
Valliant JF. A bridge not too far: linking disciplines through molecular imaging probes. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1258-68. PMID 20660374 DOI: 10.2967/jnumed.109.068312 |
0.189 |
|
| 2014 |
Dzandzi JP, Vera DR, Valliant JF. A hybrid solid-fluorous phase radioiodination and purification platform. Journal of Labelled Compounds & Radiopharmaceuticals. 57: 551-7. PMID 25069901 DOI: 10.1002/jlcr.3214 |
0.185 |
|
| 2009 |
Armstrong AF, Lebert JM, Brennan JD, Valliant JF. Functionalized carborane complexes of the [M(CO)2(NO)] 2+ core (M = 99mTc, Re): A new class of organometallic probes for correlated in vitro and in vivo imaging Organometallics. 28: 2986-2992. DOI: 10.1021/Om8011807 |
0.183 |
|
| 2011 |
Louie AS, Vasdev N, Valliant JF. Preparation, characterization, and screening of a high affinity organometallic probe for α-adrenergic receptors. Journal of Medicinal Chemistry. 54: 3360-7. PMID 21428421 DOI: 10.1021/Jm2001162 |
0.182 |
|
| 2016 |
Al-Karmi S, Albu SA, Vito A, Janzen N, Czorny S, Banevicius L, Nanao M, Zubieta J, Capretta A, Valliant JF. Preparation of a 18F-Labeled Hydrocyanine Dye as a MultiModal Probe for Reactive Oxygen Species. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 27768812 DOI: 10.1002/Chem.201604473 |
0.181 |
|
| 2011 |
Braband H, Tooyama Y, Fox T, Simms R, Forbes J, Valliant JF, Alberto R. Fac-[TcO3(tacn)]+: A versatile precursor for the labelling of pharmacophores, amino acids and carbohydrates through a new ligand-centred labelling strategy Chemistry - a European Journal. 17: 12967-12974. DOI: 10.1002/chem.201101275 |
0.177 |
|
| 2016 |
Genady AR, Janzen N, Banevicius L, El-Gamal M, El-Zaria ME, Valliant JF. Preparation and Evaluation of Radiolabeled Antibody Recruiting Small Molecules that Target Prostate Specific Membrane Antigen (PSMA) for Combined Radiotherapy and Immunotherapy. Journal of Medicinal Chemistry. PMID 26894427 DOI: 10.1021/acs.jmedchem.5b01881 |
0.177 |
|
| 2014 |
El-Zaria ME, Keskar K, Genady AR, Ioppolo JA, McNulty J, Valliant JF. High yielding synthesis of carboranes under mild reaction conditions using a homogeneous silver(I) catalyst: direct evidence of a bimetallic intermediate. Angewandte Chemie (International Ed. in English). 53: 5156-60. PMID 24700630 DOI: 10.1002/Anie.201311012 |
0.174 |
|
| 2004 |
Stephenson KA, Zubieta J, Banerjee SR, Levadala MK, Taggart L, Ryan L, McFarlane N, Boreham DR, Maresca KP, Babich JW, Valliant JF. A new strategy for the preparation of peptide-targeted radiopharmaceuticals based on an fmoc-lysine-derived single amino acid chelate (SAAC). automated solid-phase synthesis, NMR characterization, and in vitro screening of fMLF(SAAC)G and fMLF[(SAAC-Re(CO)3)+]G. Bioconjugate Chemistry. 15: 128-36. PMID 14733592 DOI: 10.1021/Bc034128S |
0.173 |
|
| 2015 |
Genady AR, Tan J, El-Zaria ME, Zlitni A, Janzen N, Valliant JF. Synthesis, characterization and radiolabeling of carborane-functionalized tetrazines for use in inverse electron demand Diels-Alder ligation reactions Journal of Organometallic Chemistry. 791: 204-213. DOI: 10.1016/j.jorganchem.2015.05.033 |
0.172 |
|
| 2015 |
Dzandzi JP, Beckford Vera DR, Genady AR, Albu SA, Eltringham-Smith LJ, Capretta A, Sheffield WP, Valliant JF. Fluorous Analogue of Chloramine-T: Preparation, X-ray Structure Determination, and Use as an Oxidant for Radioiodination and s-Tetrazine Synthesis. The Journal of Organic Chemistry. 80: 7117-25. PMID 26030355 DOI: 10.1021/acs.joc.5b00988 |
0.169 |
|
| 2016 |
Juergens RA, Zukotynski KA, Singnurkar A, Snider DP, Valliant JF, Gulenchyn KY. Imaging Biomarkers in Immunotherapy. Biomarkers in Cancer. 8: 1-13. PMID 26949344 DOI: 10.4137/BIC.S31805 |
0.167 |
|
| 2010 |
Cooke M, Valliant JF. Metallocarborane-based bisphosphonates for tumour imaging and therapy Nuclear Medicine and Biology. 37: 681-682. DOI: 10.1016/j.nucmedbio.2010.04.170 |
0.165 |
|
| 2005 |
Parrott MC, Marchington EB, Valliant JF, Adronov A. Synthesis and properties of carborane-functionalized aliphatic polyester dendrimers. Journal of the American Chemical Society. 127: 12081-9. PMID 16117549 DOI: 10.1021/Ja053730L |
0.165 |
|
| 2021 |
Rathmann SM, Genady AR, Janzen N, Anipindi V, Czorny S, Rullo AF, Sadeghi S, Valliant JF. A Versatile Platform for the Development of Radiolabeled Antibody-Recruiting Small Molecules. Molecular Pharmaceutics. 18: 2647-2656. PMID 34160225 DOI: 10.1021/acs.molpharmaceut.1c00187 |
0.161 |
|
| 2014 |
Valliant JF, Patel R, Vito A. Synthesis and evaluation of single amino acid chelate (SAAC) tetrazine derivatives for bioorthogonal conjugation with Re/99mTc Nuclear Medicine and Biology. 41: 614-615. DOI: 10.1016/j.nucmedbio.2014.05.106 |
0.157 |
|
| 2014 |
El-Zaria ME, Genady AR, Janzen N, Petlura CI, Beckford Vera DR, Valliant JF. Preparation and evaluation of carborane-derived inhibitors of prostate specific membrane antigen (PSMA). Dalton Transactions (Cambridge, England : 2003). 43: 4950-61. PMID 24481236 DOI: 10.1039/c3dt53189a |
0.156 |
|
| 2017 |
Vito A, Alarabi H, Czorny S, Beiraghi O, Kent J, Janzen N, Genady AR, Al-Karmi SA, Rathmann S, Naperstkow Z, Blacker M, Llano L, Berti PJ, Valliant JF. Correction: A 99mTc-Labelled Tetrazine for Bioorthogonal Chemistry. Synthesis and Biodistribution Studies with Small Molecule trans-Cyclooctene Derivatives. Plos One. 12: e0171909. PMID 28166295 DOI: 10.1371/journal.pone.0171909 |
0.155 |
|
| 2003 |
Parrott MC, Marchington EB, Valliant JF, Adronov A. Preparation of synthons for carborane containing macromolecules Macromolecular Symposia. 196: 201-211. DOI: 10.1002/Masy.200390161 |
0.155 |
|
| 2014 |
Edem PE, Czorny S, Valliant JF. Synthesis and evaluation of radioiodinated acyloxymethyl ketones as activity-based probes for cathepsin B. Journal of Medicinal Chemistry. 57: 9564-77. PMID 25360988 DOI: 10.1021/jm501357r |
0.153 |
|
| 2021 |
Bailey JJ, Wuest M, Wagner M, Bhardwaj A, Wängler C, Wängler B, Valliant JF, Schirrmacher R, Wuest F. Synthesis and Preclinical Evaluation of [F]SiFA-PSMA Inhibitors in a Prostate Cancer Model. Journal of Medicinal Chemistry. 64: 15671-15689. PMID 34672630 DOI: 10.1021/acs.jmedchem.1c00812 |
0.151 |
|
| 2024 |
Wyszatko K, Janzen N, Silva LR, Kwon L, Komal T, Ventura M, Venugopal C, Singh SK, Valliant JF, Sadeghi S. Zr-labeled ImmunoPET targeting the cancer stem cell antigen CD133 using fully-human antibody constructs. Ejnmmi Research. 14: 29. PMID 38498285 DOI: 10.1186/s13550-024-01091-9 |
0.15 |
|
| 2010 |
Sundararajan C, Besanger TR, Labiris R, Guenther KJ, Strack T, Garafalo R, Kawabata TT, Finco-Kent D, Zubieta J, Babich JW, Valliant JF. Synthesis and characterization of rhenium and technetium-99m labeled insulin. Journal of Medicinal Chemistry. 53: 2612-21. PMID 20235598 DOI: 10.1021/Jm100096C |
0.149 |
|
| 1998 |
Bell RA, McCarry BE, Valliant JF. The Synthesis, NMR Spectroscopy, and X-ray Structure of a New Rhenium N2S2 Chelate Complex Inorganic Chemistry. 37: 3517-3520. |
0.145 |
|
| 2004 |
King AS, Ferguson G, Britten JF, Valliant JF. Sterically hindered and robust pnictogen ligands derived from carboranes: synthesis and X-ray structure determination of tris(1'-methyl(1,2-dicarba-closo-dodecaboran-1-yl))phosphine, tris(1'-methyl(1,2-dicarba-closo-dodecaboran-1-yl))arsine and chloro(tris(1'-methyl(1,2-dicarba-closo-dodecaboran-1-yl))phosphine)gold(I). Inorganic Chemistry. 43: 3507-13. PMID 15154815 DOI: 10.1021/ic049947i |
0.144 |
|
| 2017 |
Bouvet V, Wuest M, Bailey JJ, Bergman C, Janzen N, Valliant JF, Wuest F. Targeting Prostate-Specific Membrane Antigen (PSMA) with F-18-Labeled Compounds: the Influence of Prosthetic Groups on Tumor Uptake and Clearance Profile. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 28639122 DOI: 10.1007/s11307-017-1102-x |
0.138 |
|
| 2010 |
Toppino A, Gullon TJ, Valliant JF. The preparation of a Tc-Labeled analogue of phenylalanine for labeling peptides Nuclear Medicine and Biology. 37: 679. DOI: 10.1016/j.nucmedbio.2010.04.163 |
0.137 |
|
| 2001 |
Valliant JF, Riddoch RW, Hughes DW, Roe DG, Fauconnier TK, Thornback JR. The solid phase synthesis and NMR spectroscopy of a 99Tc chelate-bombesin derived peptide conjugate Inorganica Chimica Acta. 325: 155-163. DOI: 10.1016/S0020-1693(01)00637-5 |
0.136 |
|
| 2010 |
Beer ML, Lemon J, Valliant JF. Preparation and evaluation of carborane analogues of tamoxifen. Journal of Medicinal Chemistry. 53: 8012-20. PMID 21028825 DOI: 10.1021/jm100758j |
0.135 |
|
| 2016 |
Bauman G, Martin P, Thiessen JD, Taylor R, Moussa M, Gaed M, Rachinsky I, Kassam Z, Chin J, Pautler S, Lee TY, Valliant JF, Ward A. [(18)F]-DCFPyL Positron Emission Tomography/Magnetic Resonance Imaging for Localization of Dominant Intraprostatic Foci: First Experience. European Urology Focus. PMID 28753797 DOI: 10.1016/J.Euf.2016.10.002 |
0.135 |
|
| 2007 |
Armstrong AF, Valliant JF. Microwave-assisted synthesis of tricarbonyl rhenacarboranes: steric and electronic effects on the 1,2 --> 1,7 carborane cage isomerization. Inorganic Chemistry. 46: 2148-58. PMID 17302405 DOI: 10.1021/ic0617543 |
0.132 |
|
| 2009 |
Green AEC, Parker SK, Valliant JF. Synthesis and screening of bifunctional radiolabelled carborane-carbohydrate derivatives Journal of Organometallic Chemistry. 694: 1736-1746. DOI: 10.1016/j.jorganchem.2008.12.063 |
0.123 |
|
| 2018 |
Molnar I, Burak E, Forbes J, Simms R, Valliant J. The next generation of radioimmunotherapy: Targeted alpha therapy (TAT) Annals of Oncology. 29: iii6. DOI: 10.1093/annonc/mdy046.020 |
0.119 |
|
| 2022 |
Maitz CA, Delaney S, Cook BE, Genady AR, Hoerres R, Kuchuk M, Makris G, Valliant JF, Sadeghi S, Lewis JS, Hennkens HM, Bryan JN, Zeglis BM. Pretargeted PET of Osteodestructive Lesions in Dogs. Molecular Pharmaceutics. PMID 35635337 DOI: 10.1021/acs.molpharmaceut.2c00220 |
0.118 |
|
| 2011 |
Gleave JA, Valliant JF, Doering LC. 99mTc-based imaging of transplanted neural stem cells and progenitor cells. Journal of Nuclear Medicine Technology. 39: 114-20. PMID 21565954 DOI: 10.2967/jnmt.111.087445 |
0.114 |
|
| 2002 |
Banerjee SR, Wei L, Levadala MK, Lazarova N, Golub VO, O'Connor CJ, Stephenson KA, Valliant JF, Babich JW, Zubieta J. [Re(III)Cl(3)] core complexes with bifunctional single amino acid chelates. Inorganic Chemistry. 41: 5795-802. PMID 12401085 DOI: 10.1021/Ic020391D |
0.107 |
|
| 2014 |
Yazdani A, Pitchunmony TS, Banevicius L, Czorny S, Valliant JF. Imidazole stabilized [2+1] Re(I)/99mTc(I) complexes as isostructural nuclear and optical probes Nuclear Medicine and Biology. 41: 616. DOI: 10.1016/j.nucmedbio.2014.05.101 |
0.104 |
|
| 2021 |
Yang DM, Li F, Bauman G, Chin J, Pautler S, Moussa M, Rachinsky I, Valliant J, Lee TY. Kinetic analysis of dominant intraprostatic lesion of prostate cancer using quantitative dynamic [F]DCFPyL-PET: comparison to [F]fluorocholine-PET. Ejnmmi Research. 11: 2. PMID 33394284 DOI: 10.1186/s13550-020-00735-w |
0.104 |
|
| 2002 |
Banerjee SR, Levadala MK, Lazarova N, Wei L, Valliant JF, Stephenson KA, Babich JW, Maresca KP, Zubieta J. Bifunctional single amino acid chelates for labeling of biomolecules with the [Tc(CO)(3)](+) and [Re(CO)(3)](+) cores. Crystal and molecular structures of [ReBr(CO)(3)(H(2)NCH(2)C(5)H(4)N)], [Re(CO)(3)[(C(5)H(4)NCH(2))(2)NH]]Br, [Re(CO)(3)[(C(5)H(4)NCH(2))(2)NCH(2)CO(2)H]]Br, [Re(CO)(3)[X(Y)NCH(2)CO(2)CH(2)CH(3)]]Br (X = Y = 2-pyridylmethyl; X = 2-pyridylmethyl, Y = 2-(1-methylimidazolyl)methyl; X = Y = 2-(1-methylimidazolyl)methyl), [ReBr(CO)(3)[(C(5)H(4)NCH(2))NH(CH(2)C(4)H(3)S)]], and [Re(CO)(3)[(C(5)H(4)NCH(2))N(CH(2)C(4)H(3)S)(CH(2)CO(2))]]. Inorganic Chemistry. 41: 6417-25. PMID 12444786 DOI: 10.1021/Ic020476E |
0.102 |
|
| 2015 |
Banerjee N, Wu TR, Chio J, Kelly R, Stephenson KA, Forbes J, Allen C, Valliant JF, Bendayan R. (125)I-Labelled 2-Iodoestrone-3-sulfate: synthesis, characterization and OATP mediated transport studies in hormone dependent and independent breast cancer cells. Nuclear Medicine and Biology. 42: 274-82. PMID 25542669 DOI: 10.1016/J.Nucmedbio.2014.10.011 |
0.101 |
|
| 2014 |
Kim DH, Blacker M, Valliant JF. Preparation and evaluation of fluorine-18-labeled insulin as a molecular imaging probe for studying insulin receptor expression in tumors. Journal of Medicinal Chemistry. 57: 3678-86. PMID 24712894 DOI: 10.1021/jm401020c |
0.1 |
|
| 2021 |
Vito A, Rathmann S, Mercanti N, El-Sayes N, Mossman K, Valliant J. Combined Radionuclide Therapy and Immunotherapy for Treatment of Triple Negative Breast Cancer. International Journal of Molecular Sciences. 22. PMID 34063642 DOI: 10.3390/ijms22094843 |
0.1 |
|
| 2002 |
Gates TK, Burkhalter J, Labadie JW, Valliant JC, Broner I. Monitoring and modeling flow and salt transport in a salinity-threatened irrigated valley Journal of Irrigation and Drainage Engineering. 128: 87-99. DOI: 10.1061/(Asce)0733-9437(2002)128:2(87) |
0.097 |
|
| 2011 |
Louie AS, Vasdev N, Valliant JF. Correction to Preparation, Characterization, and Screening of a High Affinity Organometallic Probe for α-Adrenergic Receptors Journal of Medicinal Chemistry. 54: 8712-8712. DOI: 10.1021/Jm201473J |
0.096 |
|
| 2019 |
Glicksman R, Metser U, Vines D, Chan R, Valliant J, Chung PWM, Gospodarowicz MK, Bayley A, Catton CN, Warde PR, Helou JA, Lalani N, Green DE, Perlis N, Fleshner NE, et al. Preliminary results of a two stage phase II study of 18F-DCFPyL PET-MR for enabling oligometastases ablative therapy in subclinical prostate cancer. Journal of Clinical Oncology. 37: 250-250. DOI: 10.1200/jco.2019.37.7_suppl.250 |
0.095 |
|
| 2021 |
Zukotynski KA, Emmenegger U, Hotte S, Kapoor A, Fu W, Blackford AL, Valliant J, Benard F, Kim CK, Markowski MC, Eisenberger MA, Antonarakis ES, Pienta KJ, Gorin MA, Lubanovic M, et al. Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 33608426 DOI: 10.2967/jnumed.120.259069 |
0.094 |
|
| 2012 |
El-Zaria ME, Janzen N, Valliant JF. Room-temperature synthesis of Re(I) and Tc(I) metallocarboranes Organometallics. 31: 5940-5949. DOI: 10.1021/om300521j |
0.093 |
|
| 2005 |
Sogbein OO, Valliant JF. 43Tc Technetium in Medicine Metallotherapeutic Drugs and Metal-Based Diagnostic Agents: the Use of Metals in Medicine. 333-358. DOI: 10.1002/0470864052.ch18 |
0.089 |
|
| 1997 |
Wong E, Fauconnier T, Bennett S, Valliant J, Nguyen T, Lau F, Lu LFL, Pollak A, Bell RA, Thornback JR. Rhenium(V) and Technetium(V) Oxo Complexes of an N 2N'S Peptidic Chelator: Evidence of Interconversion between the Syn and Anti Conformations Inorganic Chemistry. 36: 5799-5808. |
0.087 |
|
| 2016 |
Bouvet V, Wuest M, Jans HS, Janzen N, Genady AR, Valliant JF, Benard F, Wuest F. Automated synthesis of [(18)F]DCFPyL via direct radiofluorination and validation in preclinical prostate cancer models. Ejnmmi Research. 6: 40. PMID 27142881 DOI: 10.1186/S13550-016-0195-6 |
0.083 |
|
| 2010 |
Lough AJ, Hicks JW, Valliant JF, Wilson AA, Vasdev N. N-(4-Meth-oxy-phen-yl)-N'-(5-nitro-1,3-thia-zol-2-yl)urea. Acta Crystallographica. Section E, Structure Reports Online. 66: o2339. PMID 21588684 DOI: 10.1107/S1600536810032186 |
0.082 |
|
| 2006 |
Parrott MC, Valliant JF, Adronov A. Thermally induced phase transition of carborane-functionalized aliphatic polyester dendrimers in aqueous media. Langmuir : the Acs Journal of Surfaces and Colloids. 22: 5251-5. PMID 16732648 DOI: 10.1021/La0529355 |
0.079 |
|
| 2021 |
Glicksman RM, Metser U, Vines D, Valliant J, Liu Z, Chung PW, Bristow RG, Finelli A, Hamilton R, Fleshner NE, Perlis N, Zlotta AR, Green D, Bayley A, Helou J, et al. Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis. European Urology. PMID 33685838 DOI: 10.1016/j.eururo.2021.02.031 |
0.077 |
|
| 2010 |
Darwish A, Cooke M, Valliant JF. bis-Benzimidazole single-amino acid chelates Nuclear Medicine and Biology. 37: 682. DOI: 10.1016/j.nucmedbio.2010.04.182 |
0.076 |
|
| 2001 |
Valliant JF, Riddoch RW, Dolovich M, Chirakal R, Hong Y, Bakale RP, Wald SA, Schaefer K. Two approaches for the syntheis of carbon-11 labeled (R) and (S)-albuterol Journal of Labelled Compounds and Radiopharmaceuticals. 44: S134-S136. DOI: 10.1002/Jlcr.2580440147 |
0.075 |
|
| 1952 |
VICTOR J, RAYMOND R, VALLIANT J, WAGNER JC, POLLACK AD. Studies on opsonins in Q fever. The Journal of Experimental Medicine. 95: 61-70. PMID 14907961 |
0.06 |
|
| 2007 |
Eckelman WC, Kilbourn MR, Joyal JL, Labiris R, Valliant JF. Justifying the number of animals for each experiment. Nuclear Medicine and Biology. 34: 229-32. PMID 17383571 DOI: 10.1016/J.Nucmedbio.2007.01.005 |
0.057 |
|
| 1952 |
VICTOR J, POLLACK AD, RAYMOND R, VALLIANT JR. Studies on phagocytosis; determination of blood opsonin for Brucella. Journal of Bacteriology. 64: 121-30. PMID 14946108 |
0.022 |
|
| 1952 |
VICTOR J, VALLIANT JR. The origin and function of opsonins in experimental brucellosis of guinea pigs. The Journal of Infectious Diseases. 91: 207-15. PMID 13011392 DOI: 10.1093/infdis/91.3.207 |
0.022 |
|
| 2012 |
Valliant J, Harrington L. Preface Pure and Applied Chemistry. 84: iv. |
0.018 |
|
| 2015 |
Hutton HE, McCaul ME, Norris J, Valliant JD, Abrefa-Gyan T, Chander G. Sex-Related Alcohol Expectancies Among African American Women Attending an Urban STI Clinic. Journal of Sex Research. 52: 580-9. PMID 25110958 DOI: 10.1080/00224499.2014.931336 |
0.014 |
|
| 1952 |
Victor J, Pollack AD, Valliant JR, Raymond R. Human blood opsonin titers against brucella Journal of the American Medical Association. 149: 809-813. PMID 14927456 DOI: 10.1001/jama.1952.02930260011004 |
0.011 |
|
| 2009 |
Ditto TD, Ritter J, Valliant J. Working model of a gossamer membrane spectrographic space telescope Proceedings of Spie - the International Society For Optical Engineering. 7436. DOI: 10.1117/12.826377 |
0.01 |
|
| 2000 |
Valliant JG, Foley MP, Bennett JM. Instrument for on-line monitoring of surface roughness of machined surfaces Optical Engineering. 39: 3247-3254. DOI: 10.1117/1.1318786 |
0.01 |
|
| Hide low-probability matches. |
